|
|
|
|
| Sequence identity confirmation for genetically modified products is a regulatory expectation. Learn how NGS can add value to your testing program, including sequence through highly complex regions such as GC rich regions or strong secondary structure, and overcome the challenge of obtaining an accurate sequence for the inverted terminal repeats found in adeno-associated virus (AAV) vectors. |
|
|
|
|
By Erin Harris, editor-in-chief, Cell & Gene | With Q1 of 2024 coming to a close, I wanted to take this opportunity to make sure you’ve read, heard, or viewed some of the insightful content we’ve created for Cell & Gene's readers since the start of the year. |
|
|
|
|
|
|
|
| Put Your AAV On The Fast-Track To The Clinic | White Paper | Catalent | Review an innovative approach to fast-tracking AAVs through a platform approach that easily scales as the project progresses to late-stage GMP production and to market. |
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
